Literature DB >> 25872478

Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death.

Chang-Meng Cui1, Jun-Ling Gao2, Ying Cui3, Li-Qian Sun3, Yong-Chao Wang2, Kai-Jie Wang3, Ran Li2, Yan-Xia Tian2, Jian-Zhong Cui1.   

Abstract

The antimalarial drug, chloroquine (CQ), has been reported as an autophagy inhibitor in a variety of disorders, including Alzheimer's disease and brain ischemia. To the best of our knowledge, no studies to date have examined the potential for CQ to provide neuroprotection in animal models of traumatic brain injury (TBI). The aim of this study was to investigate the neuroprotective actions of CQ in TBI and to determine the mechanisms underlying this effect. Rats were immediately subjected to a diffuse cortical impact injury caused by a modified weight-drop device and divided randomly into three groups: sham-operated, CQ treatment and vehicle. The CQ treatment group was administered CQ (intraperitoneally, 3 mg/kg body weight) immediately following the induction of injury. The co-localization of neuron-specific nuclear protein (NeuN) and microtubule-associated protein 1 light chain 3 (LC3), was followed by immunofluorescent staining. The expression of LC3 and inflammatory cytokines was identified by western blot analysis. Wet-dry weight method was utilized to evaluate TBI-induced brain edema. Motor function was evaluated using the Neurological Severity Score (NSS) scale and the Morris water maze was employed to assess spatial learning ability. This study demonstrated that the administration of CQ attenuates TBI-induced cerebral edema, and the associated motor and cognitive functional deficits that occur post-injury. Following the induction of cerebral trauma, CQ treatment significantly suppressed neuronal autophagy and reduced expression levels of the inflammatory cytokines, interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), in the rat hippocampus. Our results have provided in vivo evidence that CQ may exert neuroprotective effects following TBI, in attenuating brain edema and improving neurological functioning, by reducing the damaging consequences of neuronal autophagy and cerebral inflammation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25872478     DOI: 10.3892/mmr.2015.3611

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  19 in total

Review 1.  Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Beth Levine; Douglas R Green; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

Review 2.  Autophagy in acute brain injury.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Klas Blomgren; Guido Kroemer
Journal:  Nat Rev Neurosci       Date:  2016-06-03       Impact factor: 34.870

3.  Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats.

Authors:  Tan Li; Yong-Mei Zhang; Dong Han; Rong Hua; Bing-Nan Guo; Shu-Qun Hu; Xian-Liang Yan; Tie Xu
Journal:  Neuromolecular Med       Date:  2017-09-15       Impact factor: 3.843

4.  Hsp70 inducer, 17-allylamino-demethoxygeldanamycin, provides neuroprotection via anti-inflammatory effects in a rat model of traumatic brain injury.

Authors:  Youquan Gu; Jun Chen; Tianhong Wang; Chaoning Zhou; Zhaodong Liu; Lanhua Ma
Journal:  Exp Ther Med       Date:  2016-10-19       Impact factor: 2.447

5.  Traumatic Brain Injury and Secondary Neurodegenerative Disease.

Authors:  William S Dodd; Eric J Panther; Kevin Pierre; Jairo S Hernandez; Devan Patel; Brandon Lucke-Wold
Journal:  Trauma Care (Basel)       Date:  2022-09-26

Review 6.  Aiming for the target: Mitochondrial drug delivery in traumatic brain injury.

Authors:  Andrew M Lamade; Elizabeth M Kenny; Tamil S Anthonymuthu; Elif Soysal; Robert S B Clark; Valerian E Kagan; Hülya Bayır
Journal:  Neuropharmacology       Date:  2018-07-30       Impact factor: 5.250

7.  Hypothyroidism Induces Interleukin-1-Dependent Autophagy Mechanism as a Key Mediator of Hippocampal Neuronal Apoptosis and Cognitive Decline in Postnatal Rats.

Authors:  Juhi Mishra; Jitendra Vishwakarma; Rafat Malik; Keerti Gupta; Rukmani Pandey; Shailendra Kumar Maurya; Asmita Garg; Manoj Shukla; Naibedya Chattopadhyay; Sanghamitra Bandyopadhyay
Journal:  Mol Neurobiol       Date:  2020-10-26       Impact factor: 5.590

8.  Screening for Efficacious Anticonvulsants and Neuroprotectants in Delayed Treatment Models of Organophosphate-induced Status Epilepticus.

Authors:  Bryan S Barker; Jay Spampanato; Hilary S McCarren; Melissa Smolik; Cecelia E Jackson; Eden N Hornung; David T Yeung; F Edward Dudek; John H McDonough
Journal:  Neuroscience       Date:  2019-11-26       Impact factor: 3.708

9.  Neurons in Vulnerable Regions of the Alzheimer's Disease Brain Display Reduced ATM Signaling.

Authors:  Xuting Shen; Jianmin Chen; Jiali Li; Julia Kofler; Karl Herrup
Journal:  eNeuro       Date:  2016-02-27

10.  Icariin Attenuates OGD/R-Induced Autophagy via Bcl-2-Dependent Cross Talk between Apoptosis and Autophagy in PC12 Cells.

Authors:  Zhen-Tao Mo; Wen-Na Li; Yu-Rong Zhai; Qi-Hai Gong
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.